Position in CCCC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,175,231
+$3,458,904 QoQ
Shares Held
894,054
+228.3% QoQ
Ownership
0.727%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,385 across 370 Biotechnology names. CCCC ranks #178 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,175,231 | 894,054 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $716,327 | 272,368 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $485,914 | 254,406 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $469,191 | 211,348 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $287,940 | 201,358 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $309,999 | 193,750 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $786,113 | 218,365 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,059,863 | 185,941 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $109,156 | 23,627 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $304,642 | 37,288 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $212,214 | 37,560 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $225,366 | 121,165 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $150,608 | 54,767 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $173,020 | 55,102 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $308,800 | 52,339 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $504,450 | 57,520 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $9,876 | 1,310 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $14,538,557 | 599,281 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $20,897,188 | 648,981 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $28,996,471 | 648,981 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $21,919,993 | 579,281 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,516,935 | 338,387 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $22,239,738 | 671,287 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||